Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › lymphatic filariasis

Lymphatic filariasis

Part of Filariasis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for lymphatic filariasis

5 trials tracked for lymphatic filariasis: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 141 citations.

5Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Phase 2 1 Other / NA 2
  1. Phase 3 Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study Completed · 141 cited
  2. Phase 3 Moxidectin for LF, Cote d'Ivoire (DOLF) Completed · 10 cited
  3. Phase 2 Effect of Albendazole Dose on Treatment of Lymphatic Filariasis Completed
  4. N/A Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India Completed
  5. N/A Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic scoping review shows declining filarial infection prevalence in Latin America from 1946 to 2025
Dermatology Cohort
Systematic scoping review shows declining filarial infection prevalence in Latin America from 1946 to 2025 Filaria Rates Drop After Mass Drug Campaigns
This systematic scoping review synthesizes data on lymphatic filariasis, onchocerciasis, and mansonellosis across Latin America from 1946 to…
Infection rates for disfiguring parasitic diseases have dropped sharply in parts of Latin America after years of mass drug campaigns, but on…
Frontiers Apr 25, 2026
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal
Infectious Disease
Cross-sectional review of mass drug administration impact on lymphatic filariasis elimination in Nepal Mass drug administration reduces lymphatic filariasis in most Nepal districts
This cross-sectional epidemiological monitoring survey review assesses lymphatic filariasis transmission in six endemic districts of Nepal f…
A survey of over 7,000 people in Nepal found that mass drug administration lowered infection rates in most areas, though three sites still n…
medRxiv Apr 24, 2026